Omeros Reports OMS721 Inhibits Thrombus Formation in Sera from aHUS Patients By: Benzinga via Benzinga November 19, 2014 at 07:21 AM EST Omeros Corporation (NASDAQ: OMER) today announced positive data using OMS721, the lead human monoclonal antibody for its ... Read More >> Related Stocks: Omeros Corp